Search details
1.
Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy.
Am J Pathol
; 187(11): 2430-2440, 2017 Nov.
Article
in English
| MEDLINE | ID: mdl-28837800
2.
Macrophages in diabetic nephropathy in patients with type 2 diabetes.
Nephrol Dial Transplant
; 32(8): 1322-1329, 2017 Aug 01.
Article
in English
| MEDLINE | ID: mdl-27416772
3.
Role of dietary interventions on microvascular health in South-Asian Surinamese people with type 2 diabetes in the Netherlands: A randomized controlled trial.
Nutr Diabetes
; 14(1): 17, 2024 Apr 10.
Article
in English
| MEDLINE | ID: mdl-38600065
4.
Ethnic differences in urinary monocyte chemoattractant protein-1 and heparanase-1 levels in individuals with type 2 diabetes: the HELIUS study.
BMJ Open Diabetes Res Care
; 10(6)2022 12.
Article
in English
| MEDLINE | ID: mdl-36564084
5.
Fidelity and evolution of recurrent FSGS in renal allografts.
J Am Soc Nephrol
; 19(11): 2219-24, 2008 Nov.
Article
in English
| MEDLINE | ID: mdl-18579640
6.
Genetic predisposition for glomerulonephritis-induced glomerulosclerosis in rats is linked to chromosome 1.
Physiol Genomics
; 35(2): 173-81, 2008 Oct 08.
Article
in English
| MEDLINE | ID: mdl-18682577
7.
Nephrin Loss Can Be Used to Predict Remission and Long-term Renal Outcome in Patients With Minimal Change Disease.
Kidney Int Rep
; 3(1): 168-177, 2018 Jan.
Article
in English
| MEDLINE | ID: mdl-29340328
8.
The use of extracellular matrix probes and extracellular matrix-related probes for assessing diagnosis and prognosis in renal diseases.
Curr Opin Nephrol Hypertens
; 13(6): 641-7, 2004 Nov.
Article
in English
| MEDLINE | ID: mdl-15483455
Results
1 -
8
de 8
1
Next >
>>